Ibrutinib Nitib 140 mg

Ibrutinib is a medication primarily used in the treatment of certain types of blood cancers, including chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), and Waldenström’s macroglobulinemia. It belongs to a class of drugs known as Bruton’s tyrosine kinase (BTK) inhibitors, which work by blocking the activity of BTK, a protein involved in the growth and survival of cancer cells. Ibrutinib is typically taken orally in capsule or tablet form.